Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of end points for treatment of neurofibromatosis 1.

Journal of child neurology - 1 Aug 2002

Korf Bruce R

Abstract excerpt

Neurofibromatosis 1 is a progressive disorder that affects multiple systems of the body. Management is currently focused on anticipatory guidance, genetic counseling, and symptomatic treatment of specific lesions, usually through surgery. Insights into pathogenesis of the disorder are beginning to suggest possible mechanisms of treatment, and clinical trials have begun for some types of lesions. The unpredictable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Clinical Trials as Topic
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Magnetic Resonance Imaging

Share to Neurofibromatosis 1

Share to Phenotype

Source

Identifiers

PMID: 12403564
DOI: 10.1177/088307380201700817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of end points for treatment of neurofibromatosis 1.PMID 12403564Read ↗

The Diagnosis and Management of Neurofibromatosis Type 1Semantic proximity Read ↗

Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trialsSemantic proximity Read ↗

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.Semantic proximity Read ↗

Pathophysiology of neurofibromatosis type 1.Semantic proximity Read ↗

Neurofibromatosis: emerging phenotypes, mechanisms and management.Semantic proximity Read ↗

Neurofibromatosis Type 1 RevisitedSemantic proximity Read ↗

Neurofibromatosis type 1.Semantic proximity Read ↗

Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenuesSemantic proximity Read ↗

Emerging therapeutic targets for neurofibromatosis type 1Semantic proximity Read ↗

Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Genotype-phenotype correlations and treatment innovation of neurofibromatosis type 1 (NF1): Current understanding and perspective.Semantic proximity Read ↗

[Progress and prospects in diagnosis and treatment of neurofibromatosis type 1].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.